▶ 調査レポート

乳がんモノクローナル抗体の世界市場:市場規模・現状・予測

• 英文タイトル:Global Breast Cancer Monoclonal Antibodies Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。乳がんモノクローナル抗体の世界市場:市場規模・現状・予測 / Global Breast Cancer Monoclonal Antibodies Market Size, Status and Forecast 2019-2025 / QYR9ST03163資料のイメージです。• レポートコード:QYR9ST03163
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、乳がんモノクローナル抗体の世界市場について調査・分析し、乳がんモノクローナル抗体の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(ネイキッド型MAbs、抱合型Mabs)、用途別(病院、小売薬局、その他)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の乳がんモノクローナル抗体市場動向
・主要企業別マーケットシェア
・乳がんモノクローナル抗体の種類別市場規模2014-2019
(ネイキッド型MAbs、抱合型Mabs)
・乳がんモノクローナル抗体の用途別市場規模2014-2019
(病院、小売薬局、その他)
・乳がんモノクローナル抗体の北米市場:主要企業・種類別/用途別市場規模
・乳がんモノクローナル抗体のヨーロッパ市場:主要企業・種類別/用途別市場規模
・乳がんモノクローナル抗体の中国市場:主要企業・種類別/用途別市場規模
・乳がんモノクローナル抗体の日本国内市場:主要企業・種類別/用途別市場規模
・乳がんモノクローナル抗体の東南アジア市場:主要企業・種類別/用途別市場規模
・乳がんモノクローナル抗体のインド市場:主要企業・種類別/用途別市場規模
・乳がんモノクローナル抗体の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Amgen、Roche、Mylan、Array BioPharma、Biocad、Boehringer Ingelheim、Bristol-Myers Squibb、Celldex Therapeutics、Celltrion、Daiichi Sankyo、GlaxoSmithKline、Immunomedics、MacroGenics、Merck、Novartis、Oncothyreon、Pfizer、Puma Biotechnology、Seattle Genetics、Sun Pharmaceutical Industries、Synta Pharmaceuticals、Teva Pharmaceuticals)
・乳がんモノクローナル抗体の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protein stimulates the growth and division of malignant cells.The breast cancer monoclonal antibodies (mAbs) market is one of the fastest-growing segments of the global mAbs market and has gained major research significance among biotech and pharmaceutical companies due to the presence of high unmet needs in this area. Antibodies are increasingly becoming the best choice to treat cancers, including breast cancer. The use of antibody-drug conjugates (ADCs),including radioimmunotherapy and antibody-directed enzyme prodrug therapy, is increasing rapidly. ADCs are highly effective cytotoxic drugs linked to mAbs. These drugs have shown to be potent and efficient in treating breast cancer. This has propelled vendors to focus on novel technologies such as Seattle Genetics (SGEN), ImmunoGen (IMGN), and Immunomedics (IMMU). The rising use of these antibodies in drug development increases revenue generation in the breast cancer mAbs market, contributing to market growth.
The breast cancer mAbs market in APAC will witness a high growth rate during the forecast period due to the better market penetration of breast cancer mAbs and biosimilars in emerging economies, especially in Japan, Australia, India, South Korea, and China. The rising number of initiatives undertaken by major vendors to assist patients in these countries is a significant contributor to the rise in sales of breast cancer mAbs in these countries. Moreover, the growing awareness about breast cancer and the available treatment alternatives will also propel growth prospects for the market growth in APAC.
In 2018, the global Breast Cancer Monoclonal Antibodies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Breast Cancer Monoclonal Antibodies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Cancer Monoclonal Antibodies development in United States, Europe and China.

The key players covered in this study
Amgen
Roche
Mylan
Array BioPharma
Biocad
Boehringer Ingelheim
Bristol-Myers Squibb
Celldex Therapeutics
Celltrion
Daiichi Sankyo
GlaxoSmithKline
Immunomedics
MacroGenics
Merck
Novartis
Oncothyreon
Pfizer
Puma Biotechnology
Seattle Genetics
Sun Pharmaceutical Industries
Synta Pharmaceuticals
Teva Pharmaceuticals

Market segment by Type, the product can be split into
Naked MAbs
Conjugated MAbs

Market segment by Application, split into
Hospitals
Retail Pharmacies
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Breast Cancer Monoclonal Antibodies status, future forecast, growth opportunity, key market and key players.
To present the Breast Cancer Monoclonal Antibodies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Breast Cancer Monoclonal Antibodies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Breast Cancer Monoclonal Antibodies Market Size Growth Rate by Type (2014-2025)
1.4.2 Naked MAbs
1.4.3 Conjugated MAbs
1.5 Market by Application
1.5.1 Global Breast Cancer Monoclonal Antibodies Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Retail Pharmacies
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Breast Cancer Monoclonal Antibodies Market Size
2.2 Breast Cancer Monoclonal Antibodies Growth Trends by Regions
2.2.1 Breast Cancer Monoclonal Antibodies Market Size by Regions (2014-2025)
2.2.2 Breast Cancer Monoclonal Antibodies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Breast Cancer Monoclonal Antibodies Market Size by Manufacturers
3.1.1 Global Breast Cancer Monoclonal Antibodies Revenue by Manufacturers (2014-2019)
3.1.2 Global Breast Cancer Monoclonal Antibodies Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Breast Cancer Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.2 Breast Cancer Monoclonal Antibodies Key Players Head office and Area Served
3.3 Key Players Breast Cancer Monoclonal Antibodies Product/Solution/Service
3.4 Date of Enter into Breast Cancer Monoclonal Antibodies Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Breast Cancer Monoclonal Antibodies Market Size by Type (2014-2019)
4.2 Global Breast Cancer Monoclonal Antibodies Market Size by Application (2014-2019)

5 United States
5.1 United States Breast Cancer Monoclonal Antibodies Market Size (2014-2019)
5.2 Breast Cancer Monoclonal Antibodies Key Players in United States
5.3 United States Breast Cancer Monoclonal Antibodies Market Size by Type
5.4 United States Breast Cancer Monoclonal Antibodies Market Size by Application

6 Europe
6.1 Europe Breast Cancer Monoclonal Antibodies Market Size (2014-2019)
6.2 Breast Cancer Monoclonal Antibodies Key Players in Europe
6.3 Europe Breast Cancer Monoclonal Antibodies Market Size by Type
6.4 Europe Breast Cancer Monoclonal Antibodies Market Size by Application

7 China
7.1 China Breast Cancer Monoclonal Antibodies Market Size (2014-2019)
7.2 Breast Cancer Monoclonal Antibodies Key Players in China
7.3 China Breast Cancer Monoclonal Antibodies Market Size by Type
7.4 China Breast Cancer Monoclonal Antibodies Market Size by Application

8 Japan
8.1 Japan Breast Cancer Monoclonal Antibodies Market Size (2014-2019)
8.2 Breast Cancer Monoclonal Antibodies Key Players in Japan
8.3 Japan Breast Cancer Monoclonal Antibodies Market Size by Type
8.4 Japan Breast Cancer Monoclonal Antibodies Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Breast Cancer Monoclonal Antibodies Market Size (2014-2019)
9.2 Breast Cancer Monoclonal Antibodies Key Players in Southeast Asia
9.3 Southeast Asia Breast Cancer Monoclonal Antibodies Market Size by Type
9.4 Southeast Asia Breast Cancer Monoclonal Antibodies Market Size by Application

10 India
10.1 India Breast Cancer Monoclonal Antibodies Market Size (2014-2019)
10.2 Breast Cancer Monoclonal Antibodies Key Players in India
10.3 India Breast Cancer Monoclonal Antibodies Market Size by Type
10.4 India Breast Cancer Monoclonal Antibodies Market Size by Application

11 Central & South America
11.1 Central & South America Breast Cancer Monoclonal Antibodies Market Size (2014-2019)
11.2 Breast Cancer Monoclonal Antibodies Key Players in Central & South America
11.3 Central & South America Breast Cancer Monoclonal Antibodies Market Size by Type
11.4 Central & South America Breast Cancer Monoclonal Antibodies Market Size by Application

12 International Players Profiles
12.1 Amgen
12.1.1 Amgen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Breast Cancer Monoclonal Antibodies Introduction
12.1.4 Amgen Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)
12.1.5 Amgen Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Breast Cancer Monoclonal Antibodies Introduction
12.2.4 Roche Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Mylan
12.3.1 Mylan Company Details
12.3.2 Company Description and Business Overview
12.3.3 Breast Cancer Monoclonal Antibodies Introduction
12.3.4 Mylan Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)
12.3.5 Mylan Recent Development
12.4 Array BioPharma
12.4.1 Array BioPharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Breast Cancer Monoclonal Antibodies Introduction
12.4.4 Array BioPharma Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)
12.4.5 Array BioPharma Recent Development
12.5 Biocad
12.5.1 Biocad Company Details
12.5.2 Company Description and Business Overview
12.5.3 Breast Cancer Monoclonal Antibodies Introduction
12.5.4 Biocad Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)
12.5.5 Biocad Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Company Details
12.6.2 Company Description and Business Overview
12.6.3 Breast Cancer Monoclonal Antibodies Introduction
12.6.4 Boehringer Ingelheim Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)
12.6.5 Boehringer Ingelheim Recent Development
12.7 Bristol-Myers Squibb
12.7.1 Bristol-Myers Squibb Company Details
12.7.2 Company Description and Business Overview
12.7.3 Breast Cancer Monoclonal Antibodies Introduction
12.7.4 Bristol-Myers Squibb Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)
12.7.5 Bristol-Myers Squibb Recent Development
12.8 Celldex Therapeutics
12.8.1 Celldex Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Breast Cancer Monoclonal Antibodies Introduction
12.8.4 Celldex Therapeutics Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)
12.8.5 Celldex Therapeutics Recent Development
12.9 Celltrion
12.9.1 Celltrion Company Details
12.9.2 Company Description and Business Overview
12.9.3 Breast Cancer Monoclonal Antibodies Introduction
12.9.4 Celltrion Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)
12.9.5 Celltrion Recent Development
12.10 Daiichi Sankyo
12.10.1 Daiichi Sankyo Company Details
12.10.2 Company Description and Business Overview
12.10.3 Breast Cancer Monoclonal Antibodies Introduction
12.10.4 Daiichi Sankyo Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)
12.10.5 Daiichi Sankyo Recent Development
12.11 GlaxoSmithKline
12.12 Immunomedics
12.13 MacroGenics
12.14 Merck
12.15 Novartis
12.16 Oncothyreon
12.17 Pfizer
12.18 Puma Biotechnology
12.19 Seattle Genetics
12.20 Sun Pharmaceutical Industries
12.21 Synta Pharmaceuticals
12.22 Teva Pharmaceuticals

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Breast Cancer Monoclonal Antibodies Key Market Segments
Table Key Players Breast Cancer Monoclonal Antibodies Covered
Table Global Breast Cancer Monoclonal Antibodies Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Type 2014-2025
Figure Naked MAbs Figures
Table Key Players of Naked MAbs
Figure Conjugated MAbs Figures
Table Key Players of Conjugated MAbs
Table Global Breast Cancer Monoclonal Antibodies Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Retail Pharmacies Case Studies
Figure Others Case Studies
Figure Breast Cancer Monoclonal Antibodies Report Years Considered
Table Global Breast Cancer Monoclonal Antibodies Market Size 2014-2025 (Million US$)
Figure Global Breast Cancer Monoclonal Antibodies Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Breast Cancer Monoclonal Antibodies Market Size by Regions 2014-2025 (Million US$)
Table Global Breast Cancer Monoclonal Antibodies Market Size by Regions 2014-2019 (Million US$)
Table Global Breast Cancer Monoclonal Antibodies Market Share by Regions 2014-2019
Figure Global Breast Cancer Monoclonal Antibodies Market Share by Regions 2014-2019
Figure Global Breast Cancer Monoclonal Antibodies Market Share by Regions 2019
Table Market Top Trends
Table Global Breast Cancer Monoclonal Antibodies Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Breast Cancer Monoclonal Antibodies Market Share by Manufacturers (2014-2019)
Figure Global Breast Cancer Monoclonal Antibodies Market Share by Manufacturers in 2018
Table Global Breast Cancer Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Breast Cancer Monoclonal Antibodies Product/Solution/Service
Table Date of Enter into Breast Cancer Monoclonal Antibodies Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Breast Cancer Monoclonal Antibodies Market Size by Type (2014-2019) (Million US$)
Table Global Breast Cancer Monoclonal Antibodies Market Size Share by Type (2014-2019)
Figure Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Type (2014-2019)
Table Global Breast Cancer Monoclonal Antibodies Market Size by Application (2014-2019) (Million US$)
Table Global Breast Cancer Monoclonal Antibodies Market Size Share by Application (2014-2019)
Figure Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Application (2014-2019)
Figure Global Breast Cancer Monoclonal Antibodies Revenue Market Share by Application in 2018
Figure United States Breast Cancer Monoclonal Antibodies Market Size 2014-2019 (Million US$)
Table United States Key Players Breast Cancer Monoclonal Antibodies Revenue (2018-2019) (Million US$)
Table United States Key Players Breast Cancer Monoclonal Antibodies Market Share (2018-2019)
Table United States Breast Cancer Monoclonal Antibodies Market Size by Type (2014-2019) (Million US$)
Table United States Breast Cancer Monoclonal Antibodies Market Share by Type (2014-2019)
Table United States Breast Cancer Monoclonal Antibodies Market Size by Application (2014-2019) (Million US$)
Table United States Breast Cancer Monoclonal Antibodies Market Share by Application (2014-2019)
Figure Europe Breast Cancer Monoclonal Antibodies Market Size 2014-2019 (Million US$)
Table Europe Key Players Breast Cancer Monoclonal Antibodies Revenue (2018-2019) (Million US$)
Table Europe Key Players Breast Cancer Monoclonal Antibodies Market Share (2018-2019)
Table Europe Breast Cancer Monoclonal Antibodies Market Size by Type (2014-2019) (Million US$)
Table Europe Breast Cancer Monoclonal Antibodies Market Share by Type (2014-2019)
Table Europe Breast Cancer Monoclonal Antibodies Market Size by Application (2014-2019) (Million US$)
Table Europe Breast Cancer Monoclonal Antibodies Market Share by Application (2014-2019)
Figure China Breast Cancer Monoclonal Antibodies Market Size 2014-2019 (Million US$)
Table China Key Players Breast Cancer Monoclonal Antibodies Revenue (2018-2019) (Million US$)
Table China Key Players Breast Cancer Monoclonal Antibodies Market Share (2018-2019)
Table China Breast Cancer Monoclonal Antibodies Market Size by Type (2014-20189) (Million US$)
Table China Breast Cancer Monoclonal Antibodies Market Share by Type (2014-2019)
Table China Breast Cancer Monoclonal Antibodies Market Size by Application (2014-2019) (Million US$)
Table China Breast Cancer Monoclonal Antibodies Market Share by Application (2014-2019)
Figure Japan Breast Cancer Monoclonal Antibodies Market Size 2014-2019 (Million US$)
Table Japan Key Players Breast Cancer Monoclonal Antibodies Revenue (2018-2019) (Million US$)
Table Japan Key Players Breast Cancer Monoclonal Antibodies Market Share (2018-2019)
Table Japan Breast Cancer Monoclonal Antibodies Market Size by Type (2014-2019) (Million US$)
Table Japan Breast Cancer Monoclonal Antibodies Market Share by Type (2014-2019)
Table Japan Breast Cancer Monoclonal Antibodies Market Size by Application (2014-2019) (Million US$)
Table Japan Breast Cancer Monoclonal Antibodies Market Share by Application (2014-2019)
Figure Southeast Asia Breast Cancer Monoclonal Antibodies Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Breast Cancer Monoclonal Antibodies Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Breast Cancer Monoclonal Antibodies Market Share (2018-2019)
Table Southeast Asia Breast Cancer Monoclonal Antibodies Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Breast Cancer Monoclonal Antibodies Market Share by Type (2014-2019)
Table Southeast Asia Breast Cancer Monoclonal Antibodies Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Breast Cancer Monoclonal Antibodies Market Share by Application (2014-2019)
Figure India Breast Cancer Monoclonal Antibodies Market Size 2014-2019 (Million US$)
Table India Key Players Breast Cancer Monoclonal Antibodies Revenue (2018-2019) (Million US$)
Table India Key Players Breast Cancer Monoclonal Antibodies Market Share (2018-2019)
Table India Breast Cancer Monoclonal Antibodies Market Size by Type (2014-2019) (Million US$)
Table India Breast Cancer Monoclonal Antibodies Market Share by Type (2014-2019)
Table India Breast Cancer Monoclonal Antibodies Market Size by Application (2014-2019) (Million US$)
Table India Breast Cancer Monoclonal Antibodies Market Share by Application (2014-2019)
Figure Central & South America Breast Cancer Monoclonal Antibodies Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Breast Cancer Monoclonal Antibodies Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Breast Cancer Monoclonal Antibodies Market Share (2018-2019)
Table Central & South America Breast Cancer Monoclonal Antibodies Market Size by Type (2014-2019) (Million US$)
Table Central & South America Breast Cancer Monoclonal Antibodies Market Share by Type (2014-2019)
Table Central & South America Breast Cancer Monoclonal Antibodies Market Size by Application (2014-2019) (Million US$)
Table Central & South America Breast Cancer Monoclonal Antibodies Market Share by Application (2014-2019)
Table Amgen Company Details
Table Amgen Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019) (Million US$)
Figure Amgen Revenue Growth Rate in Breast Cancer Monoclonal Antibodies Business (2014-2019)
Table Amgen Recent Development
Table Roche Company Details
Table Roche Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Breast Cancer Monoclonal Antibodies Business (2014-2019)
Table Roche Recent Development
Table Mylan Company Details
Table Mylan Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Breast Cancer Monoclonal Antibodies Business (2014-2019)
Table Mylan Recent Development
Table Array BioPharma Company Details
Table Array BioPharma Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)(Million US$)
Figure Array BioPharma Revenue Growth Rate in Breast Cancer Monoclonal Antibodies Business (2014-2019)
Table Array BioPharma Recent Development
Table Biocad Company Details
Table Biocad Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)(Million US$)
Figure Biocad Revenue Growth Rate in Breast Cancer Monoclonal Antibodies Business (2014-2019)
Table Biocad Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Breast Cancer Monoclonal Antibodies Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Breast Cancer Monoclonal Antibodies Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Celldex Therapeutics Company Details
Table Celldex Therapeutics Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)(Million US$)
Figure Celldex Therapeutics Revenue Growth Rate in Breast Cancer Monoclonal Antibodies Business (2014-2019)
Table Celldex Therapeutics Recent Development
Table Celltrion Company Details
Table Celltrion Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)(Million US$)
Figure Celltrion Revenue Growth Rate in Breast Cancer Monoclonal Antibodies Business (2014-2019)
Table Celltrion Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Revenue in Breast Cancer Monoclonal Antibodies Business (2014-2019)(Million US$)
Figure Daiichi Sankyo Revenue Growth Rate in Breast Cancer Monoclonal Antibodies Business (2014-2019)
Table Daiichi Sankyo Recent Development
Table GlaxoSmithKline Company Details
Table Immunomedics Company Details
Table MacroGenics Company Details
Table Merck Company Details
Table Novartis Company Details
Table Oncothyreon Company Details
Table Pfizer Company Details
Table Puma Biotechnology Company Details
Table Seattle Genetics Company Details
Table Sun Pharmaceutical Industries Company Details
Table Synta Pharmaceuticals Company Details
Table Teva Pharmaceuticals Company Details
Table Global Breast Cancer Monoclonal Antibodies Market Size by Regions (Million US$) 2019-2025
Figure Global Breast Cancer Monoclonal Antibodies Market Size Share by Regions (2019-2025)
Figure Global Breast Cancer Monoclonal Antibodies Market Size Share by Regions in 2025
Figure United States Breast Cancer Monoclonal Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure Europe Breast Cancer Monoclonal Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure China Breast Cancer Monoclonal Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure Japan Breast Cancer Monoclonal Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Breast Cancer Monoclonal Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure India Breast Cancer Monoclonal Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Breast Cancer Monoclonal Antibodies Market Size Forecast (2019-2025)(Million USD)
Table Global Breast Cancer Monoclonal Antibodies Market Size by Product (2019-2025) (Million US$)
Figure Global Breast Cancer Monoclonal Antibodies Market Size by Product (2019-2025)
Figure Global Breast Cancer Monoclonal Antibodies Market Size by Product in 2025
Table Global Breast Cancer Monoclonal Antibodies Market Size by Application (2019-2025) (Million US$)
Figure Global Breast Cancer Monoclonal Antibodies Market Size by Application (2019-2025)
Figure Global Breast Cancer Monoclonal Antibodies Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources